Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Net Income towards Common Stockholders (2023 - 2025)

Upstream Bio (UPB) has 3 years of Net Income towards Common Stockholders data on record, last reported at -$33.7 million in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders fell 60.45% year-over-year to -$33.7 million; the TTM value through Sep 2025 reached -$122.8 million, down 124.84%, while the annual FY2024 figure was -$76.4 million, 99.7% down from the prior year.
  • Net Income towards Common Stockholders reached -$33.7 million in Q3 2025 per UPB's latest filing, up from -$40.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$6.3 million in Q3 2023 and bottomed at -$40.0 million in Q2 2025.
  • Average Net Income towards Common Stockholders over 3 years is -$23.0 million, with a median of -$21.4 million recorded in 2024.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 236.37% in 2024, then plummeted 60.45% in 2025.
  • A 3-year view of Net Income towards Common Stockholders shows it stood at -$6.3 million in 2023, then tumbled by 248.47% to -$21.8 million in 2024, then plummeted by 54.88% to -$33.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$33.7 million in Q3 2025, -$40.0 million in Q2 2025, and -$27.3 million in Q1 2025.